Mitochondrial oxidative stress

Mitochondrial oxidative stress is a pathological state resulting from an imbalance between the generation of reactive oxygen species (ROS) and the antioxidant defense mechanisms within the mitochondria (Murphy, 2009). As the primary site of ATP production via the electron transport chain, mitochondria are major sources of superoxide and hydrogen peroxide, which can damage mitochondrial DNA, proteins, and lipids if not properly neutralized (Sies, 2015). This oxidative damage leads to mitochondrial dysfunction, impaired energy metabolism, and the activation of apoptotic pathways, contributing significantly to the progression of neurodegenerative, cardiovascular, and metabolic diseases (Smith et al., 2012). Therapeutic interventions aim to mitigate this stress using targeted antioxidants that specifically accumulate within the organelle or by stabilizing mitochondrial membranes to prevent ROS leakage (Szeto, 2014). However, because low levels of ROS serve as essential signaling molecules, pharmacological modulation must be carefully balanced to avoid disrupting normal cellular physiology.

Other names

Mitochondrial reactive oxygen species productionMitochondrial redox imbalanceMitochondrial oxidative damagemtROS production

Mitochondria-targeted antioxidants (e.g., MitoQ) utilize lipophilic cations to accumulate in the mitochondrial matrix and scavenge reactive oxygen species, while compounds like elamipretide bind to cardiolipin to stabilize the inner mitochondrial membrane and optimize electron transport chain function (Szeto, 2014; Smith et al., 2012).